LEP and COVID-19: The increased WAT inflammation seen in COVID-19 patients (39) and the relationship between increased levels of the WAT-derived adipokine leptin and lung dysfunction (40) suggests that WAT itself may play a role in the effects of obesity on COVID-19 severity.